Larvol Delta - Inhibikase-Therapeutics-Announces-Dosing-of-First-Patient-in-its-Phase-2a-3920139-Clinical-Trial-of-IkT148009-to-Treat-Parkinson39s-Disease

IkT-148009 - Inhibikase, Clintrex

https://www.prnewswire.com/news-releases/inhibikase-therapeutics-announces-dosing-of-first-patient-in-its-phase-2a-201-clinical-trial-of-ikt-148009-to-treat-parkinsons-disease-301610317.html

Aug 23, 2022

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next